<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87299">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01848951</url>
  </required_header>
  <id_info>
    <org_study_id>287.13.FB</org_study_id>
    <nct_id>NCT01848951</nct_id>
  </id_info>
  <brief_title>Comparison of Epidural and TAP Block in Abdominal Surgery</brief_title>
  <official_title>Comparison of Epidural Analgesia With Bilateral Dual TAP Infiltration Block With Liposomal Bupivacaine in Patients With Major Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study intends to examine this rational by comparing the infiltrative
      transversusabdominis plane (TAP) block with liposomal bupivacaine to EA in major abdominal
      surgery . The efficacy of the TAP block for abdominal surgery is well documented in the
      literature (McDonnell 2007) (Kadam 2011), but there are no studies utilizing long-acting
      bupivacaine. The investigators believe the primary outcome will demonstrate no difference
      between the two in terms of pain scores and opioid consumption. The investigators anticipate
      that patients who have undergone TAP blocks will have improved secondary outcomes with
      respect to a decreased costs, urinary retention, and hypotension.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Difference between the two in terms of pain scores andopioid consumption</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>patients who have undergone TAP blocks will have improved secondary outcomes with respect to a decreased costs, urinary retention, and hypotension.</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pain Management</condition>
  <condition>General Surgery</condition>
  <arm_group>
    <arm_group_label>Epidural</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural</intervention_name>
    <arm_group_label>Epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TAP Block</intervention_name>
    <arm_group_label>TAP Block</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult subjects undergoing major abdominal surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subject &gt;/= 19 years of age

          -  Undergoing major abdominal surgery

          -  able to provide written informed consent

        Exclusion Criteria:

          -  chronic opioid use

          -  allergies to amide anesthetics

          -  inability to undergo general anesthesia

          -  pregnancy

          -  any existence of contraindications to regional anesthesia in the presence of
             antiplatelet or anticoagulative drugs

          -  or evidence of gross neurological dysfunction of the lower extremity
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stacey L Therrien, BS</last_name>
      <phone>402-559-2905</phone>
      <email>stherrien@unmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 3, 2013</lastchanged_date>
  <firstreceived_date>April 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska</investigator_affiliation>
    <investigator_full_name>Thomas Nicholas IV MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
